JENRIN DISCOVERY, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for JENRIN DISCOVERY, INC..The latest application filed is for "cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes".

Company Profile

0.24.0

JENRIN DISCOVERY, INC. - Wilmington DE
Jenrin Discovery, Inc. - West Chester PA
Jenrin Discovery, Inc. - West Cheste PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 9,987,253 - McElroy , et al. June 5, 2	2018-06-05
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 9,517,228 - McElroy , et al. December 13, 2	2016-12-13
Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers Grant 9,133,127 - McElroy , et al. September 15, 2	2015-09-15
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 8,853,252 - McElroy , et al. October 7, 2	2014-10-07
4-quinolinemethanols as anti-malarial agents Grant 8,716,265 - McElroy , et al. May 6, 2	2014-05-06
Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers Grant 8,680,131 - McElroy , et al. March 25, 2	2014-03-25
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 8,648,072 - McElroy , et al. February 11, 2	2014-02-11
Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 8,580,768 - McElroy , et al. November 12, 2	2013-11-12
MAO-B inhibitors useful for treating obesity Grant 8,541,475 - McElroy , et al. September 24, 2	2013-09-24
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 8,334,282 - McElroy , et al. December 18, 2	2012-12-18
Purine compounds as cannabinoid receptor blockers Grant 8,252,791 - McElroy , et al. August 28, 2	2012-08-28
Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity Grant 8,236,821 - McElroy , et al. August 7, 2	2012-08-07
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 8,217,038 - McElroy , et al. July 10, 2	2012-07-10
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 8,138,216 - McElroy , et al. March 20, 2	2012-03-20
Substituted picolinamides as MAO-B inhibitors useful for treating obesity Grant 8,138,209 - McElroy , et al. March 20, 2	2012-03-20
Cannabinoid receptor antagonists/inverse agonists useful for treating obesity Grant 8,133,904 - McElroy , et al. March 13, 2	2012-03-13
MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesity Grant 8,124,802 - McElroy , et al. February 28, 2	2012-02-28
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 8,088,809 - McElroy , et al. January 3, 2	2012-01-03
Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity Grant 8,088,926 - McElroy , et al. January 3, 2	2012-01-03
Cannabinoid receptor antagonists/inverse agonists useful for treating obesity Grant 7,687,481 - McElroy , et al. March 30, 2	2010-03-30
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 7,666,889 - McElroy , et al. February 23, 2	2010-02-23
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 7,655,685 - McElroy , et al. February 2, 2	2010-02-02
MAO-B inhibitors useful for treating obesity Grant 7,649,115 - McElroy , et al. January 19, 2	2010-01-19
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 7,482,470 - McElroy , et al. January 27, 2	2009-01-27

Company Registrations

NCAGE Code	5RL35	JENRIN DISCOVERY INC.
CAGE Code	5RL35	JENRIN DISCOVERY, INC.
DUNS	831497891	JENRIN DISCOVERY, INC.
SEC	0001401479	Jenrin Discovery Inc of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.